Radiolabeled farnesyl-protein transferase inhibitors

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 185, 424 189, 544336, 544386, 544392, 544406, A61K 5104, C07D24100

Patent

active

060600381

ABSTRACT:
The present invention is directed toward radiolabeled farnesyl-protein transferase inhibitor compounds which are useful to label FPTase in assays, whether cell-based, tissue-based or in whole animal. The tracers can also be used in competitive binding assays to obtain information on the interaction of unlabeled FTIs with FPTase.

REFERENCES:
patent: 4960815 (1990-10-01), Moos
patent: 4994258 (1991-02-01), Burns et al.
patent: 5141851 (1992-08-01), Brown et al.
patent: 5238922 (1993-08-01), Graham et al.
patent: 5340828 (1994-08-01), Graham et al.
patent: 5352705 (1994-10-01), Deana et al.
patent: 5439918 (1995-08-01), De Solms et al.
patent: 5504212 (1996-04-01), De Solms et al.
patent: 5534537 (1996-07-01), Ciccarone et al.
patent: 5571835 (1996-11-01), Anthony et al.
patent: 5578629 (1996-11-01), Ciccarone et al.
patent: 5609849 (1997-03-01), Kung
Gibbs, J.B. et al., "Selective Inhibition of Farnesyl-Protein Transferase Blocks Ras Processing in Vivo," The Journal of Biological Chemistry, vol. 268, No. 11, pp. 7617-7620 (1993).
Goldstein, J.L. et al., "Nonfarnesylated Tetrapeptide Inhibitors of Protein Farnesyltransferase," The Journal of Biological Chemistry, vol. 266, No. 24, pp. 15575-15578 (1991).
Graham, S.L., "Inhibitors of protein farnesylation: a new approach to cancer chemotherapy ," Exp. Opin. Ther. Patents vol. 5 (12), pp. 1269-1285 (1995).
James, G., et al., "Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in Vitro," The Journal of Biological Chemistry, vol. 270, No. 11, pp. 6221-6226 (1995).
Kohl, N.E., et al., "Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice," Nature Medicine, vol. 1, No. 8, pp. 792-797 (1995).
Kohl, N.E. et al., "Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice", Proc. Natl. Acad. Sci. USA, Med. Sciences, vol. 91, pp. 9141-9145 (1994).
Kohl, N.E. et al., "Selective Inhibition of ras-Dependent Transformation by a Farnesyltransferase Inhibitor", Science, vol. 260, pp. 1934-1937 (1993).
Pompliano, D.L., "Steady-State Kinetic Mechanism of Ras Farnesyl: Protein Transferase," Biochemistry, vol. 31, pp. 3800-3807 (1992).
Sepp-Lorenzino, L., et al., "A Pepitodomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines," Cancer Research, vol. 55, pp. 5302-5309 (1995).
Graham, S.L. et al., "Inhibitors of protein farnesylation," Exp. Opin. Ther. Patents, vol. 6 (12), pp. 1295-1304 (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Radiolabeled farnesyl-protein transferase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled farnesyl-protein transferase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled farnesyl-protein transferase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1061831

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.